Ashwin Karanam
Impact in
- Toxicology top 10%
- Forensic Toxicology and Drug Analysis
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment
Papers in
-
- Pharmacological Effects and Toxicity Studies 4
-
- Pregnancy and Medication Impact 4
- Co-authors
- Angela K. Birnbaum (7 shared papers)Susan E. Marino (2 shared papers)Ilo E. Leppik (2 shared papers)Rory P. Remmel (2 shared papers)Christopher M. Barkley (1 shared paper)Page B. Pennell (4 shared papers)Sílvia M. Illamola (1 shared paper)Elena Y. Enioutina (1 shared paper)
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)SpringerPlus (1 paper)The Journal of Clinical Pharmacology (1 paper)Therapeutic Drug Monitoring (1 paper)Cancer Medicine (1 paper)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Ashwin Karanam
13 papers receiving 341 citations
Peers
Comparison fields: 5 of 74
- Toxicology 23
- Psychiatry and Mental health 100
- Pharmacology 110
- Pediatrics, Perinatology and Child Health 114
- Complementary and alternative medicine 33
Countries citing papers authored by Ashwin Karanam
This map shows the geographic impact of Ashwin Karanam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Karanam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Karanam more than expected).
Fields of papers citing papers by Ashwin Karanam
This network shows the impact of papers produced by Ashwin Karanam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Karanam. The network helps show where Ashwin Karanam may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashwin Karanam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 97 | |
| 2 | 2019 | 77 | |
| 3 | 2020 | 67 | |
| 4 | 2016 | 26 | |
| 5 | 2018 | 25 | |
| 6 | 2018 | 19 | |
| 7 | 2016 | 13 | |
| 8 | 2020 | 7 | |
| 9 | 2021 | 6 | |
| 10 | 2025 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2015 | 3 |
About Ashwin Karanam
Ashwin Karanam is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Psychiatry and Mental health, Pharmacology and Oncology, having authored 13 papers that have together received 352 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (4 papers), Pregnancy and Medication Impact (4 papers), Epilepsy research and treatment (4 papers), Blood disorders and treatments (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Cannabis and Cannabinoid Research (2 papers), Multiple and Secondary Primary Cancers (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Toxicology (23 citations), Psychiatry and Mental health (100 citations), Pharmacology (110 citations), Pediatrics, Perinatology and Child Health (114 citations) and Complementary and alternative medicine (33 citations). Ashwin Karanam has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Angela K. Birnbaum, Susan E. Marino, Ilo E. Leppik, Rory P. Remmel, Christopher M. Barkley, Page B. Pennell, Sílvia M. Illamola, Elena Y. Enioutina, Л.В. Крепкова and Catherine M.T. Sherwin. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, SpringerPlus, The Journal of Clinical Pharmacology, Therapeutic Drug Monitoring and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.